Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and Hydroxychloroquine in Severe COVID-19
NCT04746365Phase 4Completed
- Sponsor
- Elaraby Hospital
- Start
- Dec 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Elaraby Hospital. Started Dec 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04746365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04746365.